@FiercePharma: Interesting Bloomberg piece on Austrian who made his millions off drug-price differences in U.K. and EU. Article | Follow @FiercePharma
> Moody's Investor Service advised that a handful of European pharmas--including Roche ($RHHBY), Sanofi ($SNY), Novartis ($NVS), GlaxoSmithKline ($GSK), and AstraZeneca ($AZN)--could see their ratings suffer on stock buybacks. Report
> The Federal Trade Commission asked Roche for more information on its attempt to buy the gene-sequencing firm Illumina ($ILMN). Report
> Jordan's Hikma Pharmaceutical saw results suffer in last spring's political unrest in the Middle East, but it's expecting improvement on new governments' spending on healthcare. Report
> Elan is selling some $381 million worth of Alkermes ($ALKS) stock gained in its sale of Elan Drug Technology, taking its stake down to 6%. Report
> Forest Laboratories ($FRX) sued three generics makers over their plans to sell a generic version of its Bystolic blood-pressure drug. Report
Biotech News
@FierceBiotech: Okairos launches pioneering mid-stage study of promising hep C vaccine. Article | Follow @FierceBiotech
@JohnCFierce: Troubled Marina Biotech does a DNAi discovery deal with scads of biobucks involved. Release | Follow @JohnCFierce
@RyanMFierce: An interesting skeptic's take on the promise of DNA sequencing personalizing healthcare. Story | Follow @RyanMFierce
@FierceMedDev: Chicago hospital doctors say iPads raise their efficiency, via Fox News. Article | Follow @FierceMedDev
> Langer upstart rakes in fresh venture cash for mucus-targeting drugs. Article
> Sir Chris Evans inspires creation of a £100M Welsh biotech fund. News
> Your name here: Max Planck Florida shops naming rights for $10M. More
> Animal rights groups in U.K. blockade supply routes for researchers. Story
> Marina inks $14M discovery pact with ProNAi. Item
Medical Device News
> Medtronic faces more shareholder ire over Infuse. More
> ViewRay closes $45M Series C. News
> Boston Sci, Vodafone partner on mobile health monitoring. Story
> Cease implanting metal hips, U.K. doctors urge. More
> Everist launches companion Dx, prognostics portfolio for colorectal cancer. News
Biomarkers News
> Inflammatory protein marks heart disease. Item
> Researchers find 5 Crohn's disease markers in Ashkenazi Jews. Story
> New biomarkers could mean a blood test for autism. More
> Chikungunya could identify high-risk patients. Article
> Genetic mutation links with age in neuroblastoma. Story
> Nuclea Bio hunts prostate markers. Item
Drug Delivery News
> Kala Pharmaceuticals, co-launched by MIT's Langer, snags $6.2M. News
> InflammaGen drug delivery weapon targets self-digestion in Phase II trial. Article
> Scientists harness molecular 'transporter' to boost drug delivery prowess. Story
And Finally... Statin drugs' potential for triggering muscle fatigue may be most pronounced in people who exercise, a rat study finds. Report